Meet NovAliX at ESMO TAT 2024, the Targeted Anticancer Therapies Congress. Organized by the European Society for Medical Oncology (ESMOP), this global meeting will take place in Paris, France, from February 26 to 28, 2024.
The ESMO TAT Congress focuses on promising new anticancer targets and agents, specifically those in early drug development. It then enables key oncology stakeholders to connect together: translational scientists, academia, methodological experts, industrials, investors and regulatory bodies.
The Congress will include speakers in four sessions, highlighting drug development, methodology, regulations, strategic financing and investment issues. Among the main topices, attendees will learn more on:
- innovation in phase I trials
- developments in preclinical modelling to support modern drug development
- novel molecular imaging technologies
- recent developments in cellular and gene-based therapies…
Meet NovAliX at ESMO TAT 2024! If you are also attending, feel free to contact us to set a meeting and catch up with our Business Development Director:
Looking for a partnership to develop therapeutic projects? Discover some of our services in Drug Discovery, Chemistry, Biophysics and Biology, Pharmacology & DMPK.
Event
Visit websiteDate
From
Feb 26, 2024
to
Feb 28, 2024
Location
Paris, France
Attendees
Anne Pecquery
BD Director, Drug Discovery and Pharmacology